Exelixis Inc (NAS:EXEL)
$ 35.81 -0.04 (-0.11%) Market Cap: 10.23 Bil Enterprise Value: 9.24 Bil PE Ratio: 22.96 PB Ratio: 4.50 GF Score: 91/100

Exelixis Inc at William Blair Growth Stock Conference Transcript

Jun 07, 2022 / 03:00PM GMT
Release Date Price: $19.47 (+3.67%)
Tsan;Yu Hsieh
William Blair & Company L.L.C., Research Division - Senior Research Analyst

Great. Good morning, everybody. Thanks for attending our Growth Stock Conference especially after 3 long years. With me today is Mike Morrissey, CEO, President of Exelixis; and also the CSO, Chief Scientific Officer, Peter Lamb.

Questions & Answers

Tsan;Yu Hsieh
William Blair & Company L.L.C., Research Division - Senior Research Analyst

So I guess to start, we'll kind of start with kind of a rhetorical question, I guess. So if you look at the Exelixis performance, stock performance this year is actually up, right? I guess the backdrop of XBI, which is down 40%, which is -- it's been a tough market for biotech. So maybe through the course of the discussion, we'll kind of discuss exploring this topic and really dig into the growth potential for future years and also the business plan.

So maybe just start, Mike, maybe this is a good area to kind of provide us with a high-level overview of the business, future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot